Study | Type of study | Objective (s) | Country | Type of institution | Integrated/ standalone system | System developer | User | Study setting | Type of medications | Name of guideline/ standard used in the system | Key finding(s) | Level of Evidence |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Siebert et al. (2019)Â [37] | RCT, Multi center | To assess a mobile device application during simulation-based resuscitations in various hospital settings | Switzerland | Academic | Standalone | Homegrown | Nurse | Pediatric emergency | Resuscitation drugs,15 drugs for continuous infusion, 19 drugs for direct intravenous injection | American Heart Association pediatric cardiac arrest algorithm | Medication errors, mean time to drug preparation and drug delivery were reduced | Â Â Â 1A |
Parush et al. (2020)Â [45] | Non- randomized CT, Cross over | to design and empirically test a graphic dosage calculator tailored for pediatric medication calculation in prehospital emergency care | Â Â Â Israel | Academic | Standalone | Homegrown | Paramedics | Pediatric emergency | pediatric emergency drugs | Â Â Â Â Â Â N/A | significantly decreasing time to calculate doses with the graphic calculator compared with the handbook | Â Â 1C |
Ni et al. (2018) [42] | Posttest | Specific aims: 1. to develop an automated system utilizing comprehensive EHR information to detect dosing related medication error in real time, 2. To prospectively evaluate system performance in NICU prior to clinical integration, and 3. to estimate the system’s potential to mitigate MAE harm for neonatal patients |     USA | Academic | Integrated | Homegrown | Clinician |   NICU | 10 high-risk continuous intravenous infusions and medications. TPN, lipids, intravenous fluids, insulin, morphine, fentanyl, milrinone, vasopressin, dopamine, and epinephrine |   NCC MERPa | improving significantly MAE detection by the system. decreasing the time of patient exposure to harm due to drug errors by the system |    2C |
Zahn et al. (2021)Â [39] | Case study, development | to describe the development and history of the pediatric drug information system (PDIS) for Germany and its evaluation by German healthcare professionals | Â Â Germany | Academic | Standalone | Homegrown | Clinician | General pediatric | Â Â Â Â Â Â Â N/A | SmPC (Summary of Product Characteristics.), ATC-code | Â Â Â Â Â Â Â Â N/A | Â Â Â Â 3A |
Reynolds et al. (2019) [41] | Multicenter pretest–posttest, control | to evaluate end-user acceptance and the effect of a commercial handheld decision support device in pediatric intensive care settings |     USA | Non-academic | Standalone | Commercial | Nurse | NICU, PICU | intravenous and other liquid medications |   NCC MERPa | this study did not reveal significant differences in cognitive load and administration errors after deploying the system |    2A |
Dodson et al. (2021)Â [36] | Case study, development | to evaluate the perceptions of a prototype of a clinical decision support tool through a mobile application for pharmacokinetics | Â Â Â Â USA | Academic | Standalone | Homegrown | Nurse | General pediatric | Â Â Â Â Â Â Â N/A | Â Â Â Â Â Â N/A | Â Â Â Â Â Â Â Â Â N/A | Â Â Â Â 3A |
Ateya et al. (2017)Â [44] | Posttest, control | To describe the insulin calculator tool, workflow, and satisfaction of clinical users and their perception of its impact on work efficiency, and quality of patient care, and measure its impact on the incidence of hypoglycemia to assess the safety of its utilization | Â Â Â Â USA | Academic | Integrated | Homegrown | Nurse | General pediatric | Â Â Â Â Â Â Insulin | Â Â Â Â Â Â N/A | there was no significant difference in hypoglycemia rates, severe hypoglycemia rates and length of stay by using the system. | Â Â Â 2B |
Levy et al. (2011)Â [40] | Case study, development | to describe the experience in relation to the deployment of the system, including integration of multiple clinical information Systems and oncology-specific configurations | Â Â Â USA | Academic | Integrated | Homegrown | Nurse | Pediatric chemotherapy | Â Â Â Â Â Â Â Â N/A | ASCO/ONS guidelines for Chemotherapy administration | Â Â Â Â Â Â Â Â Â Â N/A | Â Â Â 3A |
Bury et al. (2005)Â [38] | RCT, cross over | to describe the design, implementation, and preliminary evaluation of the LISA system | Â Â Â UK | Academic | Integrated | Homegrown | Clinician | Pediatric chemotherapy | Oral chemotherapy | Â Â Â Â Â PROforma | using LISA reduced the time novices, while increasing the time taken by experts and did not have a significant impact on the time taken by intermediates in dose adjustment decreasing error in dose calculation | Â Â Â 1B |
aDamhoff et al. (2014)Â [43] | Non-randomized CT, Crossover | to assess the accuracy of the eBroselow system and the time needed to prepare medications during pediatric simulated resuscitations compared with standard dosing references | Â Â Â USA | Academic | Standalone | Commercial | Nurse | Pediatric emergency | Pediatric emergency drugs | NDCÂ (National drug code) | Elimination of dose calculation errors by the system, decreasing the time to prepare medications | Â Â Â 1C |
Shannon et al. (2002)Â [35] | Non-randomized CT | to design a computerized system for calculating resuscitation requirements and testing this system to ensure that it gives accurate and fast results | Â Â Â UK | Non- academic | Standalone | Homegrown | Clinician | Pediatric emergency | 10 different drugs for resuscitation and Antibiotic | Â Â Â Â Â Â N/A | decreasing dose errors by the system, decreasing the time to prepare medications | Â Â Â 1D |
Ellis et al (2012)Â [34] | Non-randomized CT, Crossover | to assess whether a graphic dose calculator, in comparison to standard paper/pencil and calculator, can support the double-checking process and reduce the rate of potential errors with high-alert drugs | Â Â Canada | Academic | Standalone | Homegrown | nurse, student nurse | Pediatric emergency | Intravenous morphine | Lexicomop /Micromedex (2011) | no significant difference to detecting error by the system and traditional method No difference to take the time to preparing medication in two groups | Â Â Â 1C |